Shows
Oncology Today with Dr Neil LovePractical Perspectives: Current Management of Chronic Myeloid Leukemia
Drs Bhavana (Tina) Bhatnagar, Amanda Blackmon, Jorge Cortes, Michael J Mauro and Neil P Shah discuss recent updates on clinical treatment strategies for chronic myeloid leukemia, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-10-231h 49
Oncology Today with Dr Neil LoveThe Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
Dr Joshua K Sabari from the NYU Langone Health Perlmutter Cancer Center and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for non-small cell lung cancer with EGFR mutations, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-10-0158 min
Oncology Today with Dr Neil LoveOptimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
Dr Tiffany Traina from the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College in New York, New York, discusses optimizing the management of metastatic BRCA-negative, triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-09-2449 min
Oncology Today with Dr Neil LoveStriving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
Dr Lipika Goyal from Stanford Cancer Center in Palo Alto, California, Dr James J Harding from Memorial Sloan Kettering Cancer Center in New York, New York, Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston, Texas, and Dr Robin K (Katie) Kelley from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, summarize the treatment landscape for patients with biliary tract cancers and review recent advancements in the field, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-09-202h 14
Oncology Today with Dr Neil LoveInside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-09-1759 min
Oncology Today with Dr Neil LoveInside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-09-111h 00
Oncology Today with Dr Neil LoveOptimizing the Management of Dedifferentiated Liposarcoma
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-09-091h 15
Oncology Today with Dr Neil LoveManagement of Metastatic Urothelial Bladder Cancer
Dr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-3030 min
Oncology Today with Dr Neil LoveSpecial Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, discusses recent advances in the treatment of breast cancer following the 2024 ASCO Annual Meeting, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-281h 15
Oncology Today with Dr Neil LoveAn interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
Prof Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the management of metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-2346 min
Oncology Today with Dr Neil LoveAn interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-2152 min
Oncology Today with Dr Neil LoveInside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-201h 01
Oncology Today with Dr Neil LoveIntegrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of antibody-drug conjugates for HR-positive and triple-negative metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-1654 min
Oncology Today with Dr Neil LoveNovel Agents and Strategies in Lung Cancer
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment of lung cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-131h 01
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-091h 02
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-0859 min
Oncology Today with Dr Neil LoveIndividualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
Dr Joyce O’Shaughnessy from Sarah Cannon Research Institute in Dallas, Texas, summarizes risk factors and targeted therapy options for patients with HR-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-061h 15
Oncology Today with Dr Neil LoveAn interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
Dr Matthew R Smith from the Massachusetts General Hospital Cancer Center in Boston summarizes recent developments presented at ASCO 2024 for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-0253 min
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 data sets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-301h 00
Oncology Today with Dr Neil LoveOptimizing the Identification of HER2-Low Breast Cancer
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-3023 min
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-2659 min
Oncology Today with Dr Neil LoveAn interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
Dr Jonathan W Goldman from UCLA Health in Santa Monica, California, summarizes recent developments presented at ASCO 2024 for patients with non-small cell lung cancer with an EGFR mutation, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-2447 min
Oncology Today with Dr Neil LoveInvestigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida and Dr Jason J Luke from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania discuss recently presented findings from ASCO on the management of melanoma and nonmelanoma skin cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-191h 06
Oncology Today with Dr Neil LoveInvestigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-171h 02
Oncology Today with Dr Neil LoveRTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-121h 02
Oncology Today with Dr Neil LoveRTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
Dr Joshua Brody from the Tisch Cancer Institute at Mount Sinai in New York, New York, Dr Ian W Flinn from OneOncology in Nashville, Tennessee, and Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss recent updates on available and novel treatment strategies for various lymphomas, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-121h 00
Oncology Today with Dr Neil LoveWhat Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Heather McArthur from UT Southwestern Medical Center in Dallas, Texas, summarize the evolution of biomarker-driven treatment approaches for triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-101h 03
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-07-011h 00
Oncology Today with Dr Neil LoveClinical Update on the Current Management of Advanced Urothelial Bladder Cancer
Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-06-171h 23
Oncology Today with Dr Neil LoveStriving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and practical considerations with ovarian function suppression for hormone receptor-positive breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-06-122h 35
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-06-111h 00
Oncology Today with Dr Neil LoveSecond Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-06-071h 02
Oncology Today with Dr Neil LoveKey Presentations on Lymphoma from Recent Major Conferences
Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-05-281h 16
Oncology Today with Dr Neil LoveRecent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-05-2433 min
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-05-131h 02
Oncology Today with Dr Neil LoveVirtual Case Library: Metastatic Triple-Negative Breast Cancer
Drs Rita Nanda, Sara M Tolaney, Julia Foldi, Laura Huppert and Saba Shaikh discuss available and emerging research, patient cases from participating junior clinical investigators and senior clinical investigator perspectives on relevant research data informing clinical decision-making for patients with metastatic triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-05-082h 13
Oncology Today with Dr Neil LoveRole of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-05-061h 07
Oncology Today with Dr Neil LoveYear in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-05-0359 min
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-05-011h 00
Oncology Today with Dr Neil LoveStriving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-04-261h 37
Oncology Today with Dr Neil LoveSpecial Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
Dr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancers Symposium and provides his perspectives on current and novel treatment approaches for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-04-2459 min
Oncology Today with Dr Neil LoveKey Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-04-231h 04
Oncology Today with Dr Neil LoveRole of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-04-1537 min
Oncology Today with Dr Neil LoveKey Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-04-121h 35
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-04-0558 min
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-04-051h 00
Oncology Today with Dr Neil LoveThe Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-04-031h 14
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-03-271h 01
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-03-261h 00
Oncology Today with Dr Neil LoveOvercoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-03-251h 19
Oncology Today with Dr Neil LovePromising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data with antibody-drug conjugates with established and investigational targets in patients with non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-03-191h 02
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
Dr Ian E Krop from the Yale Cancer Center in New Haven, Connecticut, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss patient cases and treatment strategies for HER2-positive and triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-03-151h 05
Oncology Today with Dr Neil LoveVirtual Case Library: Metastatic Urothelial Bladder Cancer
Drs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator faculty on data informing their decision-making for patients with metastatic urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-03-132h 08
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
Dr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-03-081h 00
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-03-061h 02
Oncology Today with Dr Neil LoveYear in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-02-2658 min
Oncology Today with Dr Neil LoveConsensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-02-231h 00
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-01-231h 01
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-01-161h 00
Oncology Today with Dr Neil LoveInside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2023-12-131h 00
Oncology Today with Dr Neil LoveImplications of Recent Data Sets for the Current and Future Management of Lung Cancer
Dr Luis Paz-Ares from the National Oncology Research Center in Madrid, Spain, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, and Dr David R Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss key presentations from the 2023 ESMO Congress for the management of lung cancer, moderated by Neil Love. Produced by Research To Practice.
CME information and select publications here.
2023-12-081h 30
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
Featuring a discussion on optimizing the management of gastroesophageal cancers with Dr Samuel J Klempner, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2023-12-051h 01
Oncology Today with Dr Neil LoveImplications of Recent Data Sets for the Current and Future Management of Breast Cancer
Dr Aditya Bardia from Massachusetts General Hospital and Dr Sara M Tolaney from the Dana-Farber Cancer Institute, both in Boston, Massachusetts, discuss key presentations on the management of breast cancer from the 2023 ESMO Congress, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2023-11-291h 03
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
Prof Eric Van Cutsem from the University Hospitals Leuven in Leuven, Belgium, discusses optimizing the management of gastroesophageal cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2023-11-141h 02
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
Dr Gail J Roboz from Weill Cornell Medicine in New York discusses the optimal management of acute myeloid leukemia and myelodysplastic syndromes, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2023-11-101h 01
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
Dr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-11-011h 03
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
Featuring a discussion on current and emerging strategies for the treatment of upper GI cancers with Dr Peter C Enzinger, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-10-201h 03
Oncology Today with Dr Neil LoveWhat Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-10-0647 min
Oncology Today with Dr Neil LovePractical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
Dr Kristen K Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Dr J Randolph Hecht from UCLA’s David Geffen School of Medicine in Santa Monica, California, discuss the current management and actual cases of relapsed/refractory metastatic colorectal cancer moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-10-061h 05
Oncology Today with Dr Neil LoveBlastic Plasmacytoid Dendritic Cell Neoplasm
Dr Naveen Pemmaraju from the University of Texas MD Anderson Cancer Center in Houston, Texas, discusses current and emerging management approaches for blastic plasmacytoid dendritic cell neoplasms moderated by Dr Neil Love.
CME information and select publications here
2023-10-0433 min
Oncology Today with Dr Neil LoveInside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
Dr Hope Rugo from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Tiffany Traina from Memorial Sloan Kettering Cancer Center in New York, New York, discuss current and emerging optimal management approaches for metastatic triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-291h 04
Oncology Today with Dr Neil LoveEmerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein degradation pathways in the treatment of multiple myeloma, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-2739 min
Oncology Today with Dr Neil LoveNovel Agents and Strategies in the Treatment of Ovarian Cancer
Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-2521 min
Oncology Today with Dr Neil LoveWhat Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
Dr Nicole Lamanna from the Columbia University Herbert Irving Comprehensive Cancer Center in New York, New York, and Dr William G Wierda from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the spectrum of toxicities associated with BTK inhibitors and strategies for their mitigation and management for patients with chronic lymphocytic leukemia and mantle cell lymphoma, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-221h 02
Oncology Today with Dr Neil LoveOptimizing the Management of Metastatic Pancreatic Cancer
Dr Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-151h 03
Oncology Today with Dr Neil LoveThe Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-131h 00
Oncology Today with Dr Neil LoveMeet The Professor: Optimizing the Management of Melanoma
Prof Georgina Long from the University of Sydney in Sydney, New South Wales, Australia, discusses optimizing the management of melanoma moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-111h 03
Oncology Today with Dr Neil LoveStriving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
Dr Corey Langer, Dr Ticiana Leal, Dr Karen Reckamp and Dr Jacob Sands discuss the optimal current management of relapsed NSCLC and provide perspectives on the future of care for patients with this disease, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-082h 43
Oncology Today with Dr Neil LoveThe Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma
Dr Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center in New York and Dr Daneng Li from City of Hope Comprehensive Cancer Center in Duarte, California, discuss the implications of recent data sets for the management of hepatocellular carcinoma moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here
2023-09-051h 02
Hematologic Oncology UpdateOncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell LymphomaFeaturing a discussion on BTK inhibitors for the management of mantle cell lymphoma with Dr Michael Wang, moderated by Dr Neil Love.2023-08-3142 min
Lung Cancer UpdateOncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingFeaturing a discussion on key presentations on lung cancer from the 2023 ASCO Annual Meeting, with Dr Matthew Gubens, moderated by Dr Neil Love.2023-08-2232 min
Gastrointestinal Cancer UpdateOncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingFeaturing a discussion on key presentations related to gastrointestinal cancers from the 2023 ASCO Annual Meeting, with Dr Philip Philip, moderated by Dr Neil Love.2023-08-1649 minGastrointestinal Cancer UpdateOncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Colorectal and Gastroesophageal CancersDr Tanios Bekaii-Saab from the Mayo Clinic in Phoenix, Arizona, discusses the role of novel therapeutic management approaches for patients with colorectal and gastroesophageal cancers, moderated by Dr Neil Love. Produced by Research To Practice.2023-08-0358 minHematologic Oncology UpdateOncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal HemoglobinuriaFeaturing a discussion on the biology and treatment of paroxysmal nocturnal hemoglobinuria with Dr Carlos de Castro, moderated by Dr Neil Love.2023-07-2642 minGastrointestinal Cancer UpdateOncology Today with Dr Neil Love: Special Edition — Management of Hepatobiliary CancersDr Robin “Katie” Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California discusses recent updates from ASCO 2023 on the management of hepatobiliary cancers, moderated by Dr Neil Love.2023-07-2553 min
Breast Cancer UpdateOncology Today with Dr Neil Love: Special Edition — Current and Future Management of Breast CancerFeaturing a discussion on recent presentations in breast cancer from the 2023 ASCO annual meeting with Dr Kevin Kalinsky, moderated by Dr Neil Love.2023-07-2158 minHematologic Oncology UpdateOncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma EditionFeaturing a discussion on newly presented data in multiple myeloma from the 2022 ASH Annual Meeting, with Dr Jacob Laubach, moderated by Dr Neil Love.2023-04-191h 14Hematologic Oncology UpdateOncology Today with Dr Neil Love — Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia EditionFeaturing a discussion on chronic lymphocytic leukemia studies presented at ASH 2022 with Dr John Allan, moderated by Dr Neil Love.2023-04-121h 19Gastrointestinal Cancer UpdateOncology Today with Dr Neil Love: Special Edition — Current Management of Hepatobiliary CancersFeaturing perspectives from Dr Lipika Goyal, moderated by Dr Neil Love.2023-04-0458 minGastrointestinal Cancer UpdateOncology Today with Dr Neil Love: Special Edition — Current Management of Gastroesophageal CancersFeaturing perspectives from Dr Zev Wainberg, moderated by Dr Neil Love.2023-04-0452 minHematologic Oncology UpdateOncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual MeetingFeaturing a discussion on lymphoma studies presented at ASH 2022, with Dr Matthew Lunning, moderated by Dr Neil Love.2023-03-021h 28Gastrointestinal Cancer UpdateOncology Today with Dr Neil Love: Management of Desmoid TumorsFeaturing a discussion on the management of desmoid tumors with Dr Mrinal Gounder, moderated by Dr Neil Love.2023-02-2854 minLung Cancer UpdateOncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer?Featuring a discussion on targeted therapy for HER2-altered non-small cell lung cancer with Dr Bob Li, moderated by Dr Neil Love.2023-02-211h 20Lung Cancer UpdateOncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable MutationFeaturing a discussion on new and emerging data in the management of NSCLC without an actionable mutation, with Dr Edward Garon, moderated by Dr Neil Love.2023-02-1349 minHematologic Oncology UpdateOncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual MeetingFeaturing a discussion on newly presented data with myelofibrosis, polycythemia vera and essential thrombocythemia with Dr Srdan Verstovsek, moderated by Dr Neil Love.2023-02-091h 19Hematologic Oncology UpdateOncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell LymphomaFeaturing a discussion on recent data with targeted therapies for the treatment of diffuse large B-cell lymphoma with Dr Gilles Salles, moderated by Dr Neil Love.2023-02-0643 minHematologic Oncology UpdateOncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual MeetingFeaturing a discussion on newly presented data in acute myeloid leukemia and myelodysplastic syndromes from the 2022 ASH Annual Meeting with Dr Richard Stone, moderated by Dr Neil Love.2023-02-021h 10Breast Cancer UpdateOncology Today with Dr Neil Love: Special Edition — Management of ER-Positive Breast CancerFeaturing a discussion on ER-positive breast cancer with Drs Erica Mayer and Ruth O’Regan, moderated by Dr Neil Love.2023-01-311h 40Breast Cancer UpdateOncology Today with Dr Neil Love: HER2-Positive Metastatic Breast CancerFeaturing a discussion of recent advances in the treatment of HER2-positive metastatic breast cancer with Professor Giuseppe Curigliano, moderated by Dr Neil Love.2023-01-2647 minGastrointestinal Cancer UpdateOncology Today with Dr Neil Love: Management of Gastroesophageal CancersFeaturing a discussion on current and emerging strategies for the treatment of upper GI malignancies with Dr Manish Shah, moderated by Dr Neil Love.2023-01-1243 min